Matches 1 - 50 out of 93 1 2 >


Match Document Document Title
US20110052538 PROBIOTIC/NON-PROBIOTIC COMBINATIONS  
This invention pertains to a method of promoting gastrointestinal health by ingesting a composition comprising one or more probiotic microorganisms, one or more carbohydrate sources, and one or...
US20140037553 BACTERIUM-BASED MICROROBOT CAPABLE OF TARGETING CANCER TISSUE  
To provide a bacterium-based microrobot which can be specifically targeted to cancer in vivo, the present invention provides a drug delivery system for cancer tissue, comprising a bacterium, and a...
US20110086011 Prevention or Treatment of Immune-Relevant Disease by Modification of Microfloral Populations  
The present invention is a method for preventing or treating an immune-relevant disease by modulating commensal microbiota populations via antibiotics, exogenous microbiota and/or probiotics.
US20150246081 PROBIOTICS WITH METHODS FOR GROWTH AND USE SEPARATELY AND IN COMBINATION  
A dietary supplement that may contain probiotics from the genera Akkermansia, Bacteriodes, Faecalibacterium, Eubacterium, Escherichia, Collinsella, Desulfovibrio, Clostridium, Mycobacterium,...
US20140294787 EXTENSIONAL VISCOSITY TO PROMOTE SAFE SWALLOWING OF FOOD BOLUSES  
Nutritional products having improved cohesiveness of food boluses and methods of making and using same are provided. The nutritional products may include nutritional compositions and high...
US20140363397 METHOD FOR TREATMENT OF DISORDERS OF THE GASTROINTESTINAL SYSTEM  
There are provided novel synthetic stool preparations comprising bacteria isolated from a fecal sample from a healthy donor. The synthetic stool preparations are used for treating disorders of the...
US20140112985 METHOD OF PREVENTION AND TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION  
This invention relates to prophylactic and/or therapeutic application of microorganism species that are, for example, administered orally as delayed release formulation designed to release its...
US20110256207 WHOLE GRAIN FLOUR AND PRODUCTS INCLUDING SAME  
The present invention is a grain product. The grain product includes a first fraction including bran. The first fraction is milled to a first particle size of less than 500 micrometers. The grain...
US20120014993 CLOSTRIDIUM TAENIOSPORUM SPORES AND SPORE APPENDAGES AS SURFACE DISPLAY HOSTS, DRUG DELIVERY DEVICES, AND NANOBIOTECHNOLOGICAL STRUCTURES  
The present disclosure relates to spore surface display compositions comprising a spore having at least one nucleic acid sequence encoding for at least one polypeptide and operable to express the...
US20120058094 COMPOSITIONS AND METHODS FOR TREATING OBESITY AND RELATED DISORDERS BY CHARACTERIZING AND RESTORING MAMMALIAN BACTERIAL MICROBIOTA  
The present invention relates to characterizing changes in mammalian intestinal microbiota associated with associated with high-fat and low-fat diets and with diets containing...
US20130089530 METHODS AND COMPOSITIONS FOR TREATING PARASITIC WORM INFECTIONS IN A MAMMAL  
The invention relates to compositions for treating parasitic worm infections in a mammal. The composition includes an amount of intracellular components of lysed, beneficial, soil-inhabiting yeast...
US20080003207 TREATING INFLAMMATORY BOWEL DISEASE WITH LIVE BACTERIA  
This invention relates to using live beneficial bacteria for treating inflammatory bowel disease, such as ulcerative colitis and Crohn's disease.
US20120027728 ADJUNCTIVE AGENT FOR LAVAGING THE ALIMENTARY CANAL COMPRISING BUTYRIC ACID BACTERIUM AND/OR LACTIC ACID BACTERIUM  
The present invention provides an adjunctive agent and a method for lavaging the alimentary canal, which is able to reduce a dose of oral cleaning agent for lavaging the alimentary canal and is...
US20110212161 TREATMENT SKIN DISORDERS  
Disclosed are a composition and a method for treating skin disorders, including rosacea, pityriasis rosea, erythema, rhinophyma, and rosacea-associated disorders including pimples, papules,...
US20130230498 REDUCING SHORT-CHAIN FATTY ACIDS AND ENERGY UPTAKE IN OBESE HUMANS BY MANAGING THEIR INTESTINAL MICROBIAL COMMUNITIES  
The present invention provides for microbial compositions and methods for reducing the concentration of short-chain fatty acids in the gut as a way to reduce energy uptake and manage obesity. More...
US20130224164 Environmental Clostridial Bacteriotherapy and Related Formulations and Methods of Manufacture and Use  
Compositions and methods for inhibiting Clostridium associated diseases are disclosed.
US20100316617 USE OF HYDROGENOTROPHIC ACETOGENIC STRAINS FOR PREVENTING OR TREATING DIGESTIVE DISORDERS  
A method of modulating the microbial balance of the digestive ecosystem in a mammal comprising administering to a mammal in need thereof a composition comprising at least one nonpathogenic,...
US20110280847 METHODS AND COMPOSITIONS FOR INHIBITING CLOSTRIDIUM DIFFICILE SPORE GERMINATION AND OUTGROWTH  
Certain bile acids, including novel bile acids, and derivatives thereof can be used to inhibit the germination of C. difficile spores and/or the growth of C. difficile cells. The methods and...
US20110223137 COMPOSITIONS FOR USE IN LOW-BIRTH WEIGHT INFANTS  
The present invention relates to compositions for use in low-birth weight infants. In particular, the compositions are probiotic compositions which are used for achieving full enteral feeding in...
US20120237544 BACTERIAL SPORE HAVING THERAPEUTIC AGENT ADSORBED ON ITS SURFACE  
The present invention relates to a method of coating a spore with one or more therapeutic agents. The present invention also relates to a coated spore obtained by the method of the present...
US20140341921 HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS  
Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and suppress immune functions....
US20130108598 METHOD FOR DIAGNOSING RISK OF TYPE 1 DIABETES AND FOR PREVENTING ONSET OF TYPE 1 DIABETES  
The invention comprises methods for diagnosing the risk of onset of type 1 diabetes and for preventing the onset of type 1 diabetes. The genetic background, metabolomes, antibodies and diversity...
US20110002914 HYBRID TETNUS TOXOID PROTEINS THAT MIGRATE RETROGRADELY AND TRANSYNAPTICALLY INTO THE CNS  
The non-toxic proteolytic C fragment of tetanus toxin (TTC peptide) has the same ability to bind nerve cells and be retrogradely transported through a synapse as the native toxin. A hybrid protein...
US20140294788 METHODS FOR ENHANCING MUSCLE PROTEIN SYNTHESIS FOLLOWING CONCURRENT TRAINING  
The present disclosure provides methods for enhancing muscle protein synthesis following physical exertion. In a general embodiment, a method for enhancing muscle protein synthesis following...
US20140037604 NUTRITIONAL COMPOSITIONS COMPRISING ALPHA-HYDROXYISOCAPROIC ACID  
Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional...
US20150238546 PROBIOTIC RECOLONISATION THERAPY  
The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in...
US20150238545 PROBIOTIC RECOLONISATION THERAPY  
The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in...
US20130266539 PROBIOTIC RECOLONISATION THERAPY  
The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in...
US20140056863 NUTRITIONAL COMPOSITIONS HAVING ALPHA-HICA AND EICOSAPENTAENOIC ACID  
Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional...
US20140056862 NUTRITIONAL COMPOSITIONS HAVING ALPHA-HICA AND ALPHA-KETOGLUTARATE  
Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional...
US20140044685 NUTRITIONAL COMPOSITIONS HAVING ALPHA-HICA AND CITRULLINE  
Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional...
US20120301450 MIXTURE, DISSOLVING SOLUTION AND PHARMACEUTICAL AGENT EACH COMPRISING THERMOPHILIC MICROORGANISM  
To provide a mixture, a dissolving solution and a pharmaceutical agent, which contain a thermophilic microorganism to make it possible to regulate a mucous membrane immune system gene cluster and...
US20110033431 TYPE A2 BOTULINUM TOXIN PREPARATION  
A pharmaceutical preparation for use in a patient who has a neutralizing antibody to a botulinum toxin from type A1 Clostridium botulinum (type A1 botulinum toxin), said preparation comprising as...
US20120207726 AUTISM-ASSOCIATED BIOMARKERS AND USES THEREOF  
The invention discloses biomarkers for human autism. The invention provides methods for treating, preventing, and diagnosing human autism and autism-related disorders.
US20110250258 TUMOR-SPECIFIC DELIVERY OF THERAPEUTIC AGENTS VIA LIPOSOMASE  
Clostridium novyi is an obligate anaerobe that can infect hypoxic regions within experimental tumors. We found that mice bearing large, established tumors were often cured when treated with C....
US20140228212 PESTICIDAL COMPOSITIONS  
Combinations suitable for agricultural use can include (I) a nematode-antagonistic biocontrol agent and (II) one or more agents selected, independently of each other, from any one of (A) to (H):...
US20080118482 TREATING MOUTH ULCER WITH LIVE BACTERIA  
This invention relates to using live beneficial bacteria for treating mouth ulcer.
US20150104423 USE OF BLOOD GROUP STATUS III  
The present invention relates to a microbial composition which is tailored based on the spectrum of microbes found more frequently from the intestine of non-secretor individuals than from the...
US20130195820 USE OF BLOOD GROUP STATUS III  
The present invention relates to a microbial composition which is tailored based on the spectrum of microbes found more frequently from the intestine of non-secretor individuals than from the...
US20140030241 NUTRITIONAL COMPOSITIONS FOR INCREASING ARGININE LEVELS AND METHODS OF USING SAME  
Nutritional compositions having dietary nucleotides, ω-3 fatty acids and citrulline are provided. The nutritional compositions may be formulated to improve T cell function, increase arginine...
US20130340123 METHOD FOR CONTROLLING NEMATODE PESTS  
Plant propagation material expressing soybean cyst nematode resistance can be treated with a nematode-antagonistic biocontrol agent. Use of the nematode-antagonistic biocontrol agent can reduce...
US20150147315 COMPOSITIONS AND METHODS OF USE  
The present invention relates to a derivative bacterial strain of an avirulent, non-pathogenic Clostridium ghonii that is capable of arresting the growth of, regressing or destroying one or more...
US20080050352 Pharmaceutical Composition Comprising Botulinum, a Non Ionic Surfactant, Sodium Chloride and Sucrose  
The invention relates to a solid or liquid pharmaceutical composition comprising botulinum neurotoxin complex (type A, B, C, D, E, F or G) or high purity botulinum neurotoxin (type A, B, C, D, E,...
US20090257992 ADJUNCTIVE AGENT FOR LAVAGING THE ALIMENTARY CANAL COMPRISING BUTYRIC ACID BACTERIUM AND/OR LACTIC ACID BACTERIUM  
The present invention provides an adjunctive agent for lavaging the alimentary canal which is able to reduce a dose of oral cleaning agent for lavaging the alimentary canal, and is capable of...
US20140234260 COMPOSITIONS AND METHODS FOR PROBIOTIC RECOLONIZATION THERAPIES  
The present invention relates to pharmaceutical compositions suitable for the treatment of chronic diseases associated with the presence of abnormal or an abnormal distribution of microflora in...
US20100226899 Categorization of Microbial Communities  
The present disclosure provides embodiments of a method for characterizing microbial populations. Exemplified by methods for characterizing microbiota in vaginal samples, the methods provided...
US20140147425 SYNERGISTIC BACTERIAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF  
Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
US20140328813 Combination Bacteriolytic Therapy for the Treatment of Tumors  
Current approaches for treating cancer are limited, in part, by the inability of drugs to affect the poorly vascularized regions of tumors. We have found that spores of anaerobic bacteria in...
US20110311500 COMBINATION BACTERIOLYTIC THERAPY FOR THE TREATMENT OF TUMORS  
Current approaches for treating cancer are limited, in part, by the inability of drugs to affect the poorly vascularized regions of tumors. We have found that spores of anaerobic bacteria in...
US20120020941 USE OF BLOOD GROUP STATUS III  
Provided is a microbial composition which is tailored based on the spectrum of microbes found more frequently from the intestine of non-secretor individuals than from the intestine of secretor...

Matches 1 - 50 out of 93 1 2 >